8-K: Earth Science Tech Reports Strong Fiscal Year End with 54% Revenue Increase in Q4

Earth Science Tech, Inc. announces a successful fiscal year end, highlighted by a 54% revenue increase in the fourth quarter and significant progress across its business segments.

Summary

• Earth Science Tech, Inc. (ETST) has released its annual letter from the CEO, detailing a year of significant progress.
• The company's RxCompoundStore.com is now licensed in 22 states, up from 2 states a year ago, with more pending.
• ETST has 31 employees and 11 independent contractors, with plans to convert contractors to full-time positions.
• The company has a five-member Board of Directors, including two independent members, and an audit committee of three members.
• ETST has retired most of its long-term liabilities, resulting in a cleaner balance sheet.
• The company has hired a new CFO and CTO to lead financial and technological transformations.
• Peaks Curative has been activated and is generating sales across its various online platforms.
• ETST repurchased 5,200,002 shares, representing 1.6% of outstanding shares, for $178,000.08, or $0.034 per share.
• The company has expanded its office and storage space by 4,000 square feet, a 200% increase.
• Peaks Curative has 5 prescribers on its platform and expects to add more.
• A lawsuit against RxCompoundStore.com was dismissed with prejudice.
• The company had at least $5.7 million in revenue in the fourth quarter, a 54% increase quarter-over-quarter.
• ETST's cash balance is roughly $700,000, a 250% increase quarter-over-quarter.
• The company is actively seeking non-dilutive acquisitions, partnerships, and investments.

Sentiment

Score: 9

Explanation: The document conveys a very positive sentiment due to the strong financial results, strategic initiatives, and management's confidence in the company's future. The significant revenue and cash balance increases, along with the share buyback program, contribute to a highly optimistic outlook.

Positives

• The company has significantly expanded its licensing for RxCompoundStore.com, increasing its market reach.
• The share buyback program demonstrates confidence in the company's value and future prospects.
• The substantial revenue and cash balance increases indicate strong financial performance.
• The expansion of office and storage space reflects the company's growth and operational needs.
• The dismissal of the lawsuit is a positive outcome, removing a potential legal risk.
• The company has retired most of its long-term liabilities, improving its financial health.

Risks

• The company's future performance is subject to risks and uncertainties, as outlined in the safe harbor statement.
• There is no guarantee that the company will complete additional acquisitions or be approved for a NASDAQ listing.
• The company's forward-looking statements are subject to change based on new information or future events.

Future Outlook

The company is actively vetting future non-dilutive acquisitions, partnerships, and investments to augment shareholder value and is not limiting its search to the health and wellness space. The company believes its current subsidiaries can continue to grow organically while it diversifies its holdings in other industries and finances the growth of its current subsidiaries.

Management Comments

• The last year has been one of incredible progress at ETST.
• We are executing!
• All of these accomplishments show the management teams commitment to growing the company and performing at a high level for our shareholders.
• ETST is growing.
• Needless to say: WE ARE EXECUTING.

Industry Context

The company's focus on compounding pharmaceuticals and telemedicine aligns with the growing trend of personalized healthcare and the increasing demand for convenient healthcare solutions. The expansion of its online platforms and licensing reflects the industry's shift towards digital health services.

Comparison to Industry Standards

• The 54% quarter-over-quarter revenue growth is a strong performance compared to many companies in the health and wellness sector, which often experience more modest growth rates.
• The 250% increase in cash balance is also a significant achievement, indicating effective financial management and operational success.
• The expansion of RxCompoundStore.com's licensing to 22 states is a notable accomplishment, as many compounding pharmacies struggle to achieve such broad geographic coverage.
• The share buyback program is a positive signal to investors, as it suggests that management believes the company's stock is undervalued.
• Compared to other small-cap companies, ETST's focus on non-dilutive acquisitions and partnerships is a strategic move to enhance shareholder value without diluting existing ownership.

Management Changes

Corporate Governance

Legal Proceedings

• A lawsuit brought against RxCompoundStore.com by a major drug manufacturer in September 2023 was dismissed with prejudice.

Stakeholder Impact

• Shareholders will benefit from the share buyback program and the company's strong financial performance.
• Employees will benefit from the company's growth and the potential for full-time positions.
• Customers will benefit from the expanded availability of RxCompoundStore.com and the services offered by Peaks Curative.
• The company's financial health and growth will benefit suppliers and creditors.

Next Steps

• The company will continue to expand its licensing for RxCompoundStore.com.
• The company will continue to convert independent contractors to full-time positions.
• The company will continue to develop and refine DocProtocol.com.
• The company will continue to repurchase shares through private transactions and then on the open market.
• The company will actively vet future non-dilutive acquisitions, partnerships, and investments.

Key Dates

Keywords

pharmaceuticals, telemedicine, compounding, revenue, share buyback, RxCompoundStore, Peaks Curative, health and wellness, acquisitions, financial results